Related Party Transactions |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Related Party Transactions | |
| Related Party Transactions | 15. Related Party Transactions The Company has engaged Boston Image Reading Center LLC (“BIRC”) to provide certain clinical development-related services. Nadia Waheed, M.D. M.P.H., the Company’s Chief Medical Officer, is a Director of BIRC. For the three months ended March 31, 2026 and 2025, the Company incurred fees of $145 and $26, respectively. As of March 31, 2026 and December 31, 2025, there was $253 and $126 recorded in accounts payable for BIRC, respectively. As of March 31, 2026 and December 31, 2025, there was $145 and $590 recorded in accrued expenses for BIRC, respectively. The Company engages BIRC in the ordinary course of our business on an arm's length basis. Jeffrey Heier, M.D., the Company’s Chief Scientific Officer, and Peter Kaiser, M.D., the Company’s Chief Development Officer, are each a shareholder of i2Vision, Inc. The Company had engaged i2Vision to provide services with respect to the clinical advancement of AXPAXLI. For the three months ended March 31, 2026, no costs for services rendered by i2Vision were incurred. For the three months ended March 31, 2025, the Company recorded a net credit of $165 related to services previously rendered by i2Vision. |